| Paphos People https://mail.paphospeople.com/ppforum/ |
|
| Cyprus to resume AZN jabs Friday https://mail.paphospeople.com/ppforum/viewtopic.php?f=2&t=35585 |
Page 1 of 1 |
| Author: | M.A.D [ Thu Mar 18, 2021 9:21 pm ] |
| Post subject: | Cyprus to resume AZN jabs Friday |
Coronavirus: Cyprus to resume AZN jabs Friday after EMA backing (Updated) Following the opinion from the European Medicines Agency (EMA), which clarified that, after a thorough investigation, there was no link between the AstraZeneca vaccine and the thromboembolic events reported by EU countries, and that the vaccine was considered safe and effective, the health ministry announced that as of Friday vaccinations with the jab would resume. People who have a scheduled appointment for vaccination are asked to go to the vaccination centre where they have secured appointments. Those who lost their appointments due to the pause in AZN jabs will learn on Friday how to reschedule during a news conference by the health ministry, it said. The EU’s drug watchdog said it was still convinced the benefits of AstraZeneca’s COVID-19 vaccine outweigh the risks following an investigation into reports of blood disorders that prompted more than a dozen nations to suspend its use. The news came as the European Medicines Agency (EMA) director Emer Cooke said the watchdog could not definitively rule out a link between blood clot incidents and the vaccine in its investigation into 30 cases of a rare blood clotting condition. But she said in a briefing the “clear” conclusion of the review was that the vaccine “benefits in protecting people from COVID-19 with the associated risk of death or hospitalisation outweighs the possible risks.” The agency will however update its guidance to include an explanation about the potential risks on both the patient leaflet and in the information for healthcare professionals, she said. “This is a safe and effective vaccine,” said Cooke. The agency has been under growing pressure to clear up safety concerns after a small number of reports in recent weeks of bleeding, blood clots and low platelet counts in people who have received the shot. The agency’s review covering 5 million people, included 30 cases of unusual blood disorders in people in the European Economic Area (EEA), which links 30 European countries. The EMA’s focus and primary concern has been on cases of blood clots in the head, a rare condition that’s difficult to treat called cerebral venous thrombosis (CVT) or a subform known as cerebral venous sinus thrombosis (CVST). More than 45 million of the shots have been administered across the EEA. At least 13 European countries, including France, Germany and Italy, have stopped administering the shot pending the review. Britain’s medicines regulator said on Thursday it was investigating five cases of CVST among people given AstraZeneca’s vaccine but it reaffirmed that the benefits of the shot far outweighed any possible risks. The World Health Organization also this week reaffirmed its support for the shot. AstraZeneca has said a review covering more than 17 million people who had received its shots in the EU and Britain had found no evidence of an increased risk of blood clots. Many governments have said the decision to pause inoculations was out of an abundance of caution. But experts have warned the political interference could undermine public confidence and hobble the bloc’s slow vaccination campaign as governments struggle to tame more infectious variants. The bloc’s vaccine roll-out has lagged the United States and former EU member Britain. https://cyprus-mail.com/2021/03/18/coronavirus-cyprus-to-resume-azn-jabs-friday-after-ema-backing-updated/ |
|
| Page 1 of 1 | All times are UTC + 2 hours [ DST ] |
| Powered by phpBB® Forum Software © phpBB Group http://www.phpbb.com/ |
|